Procaccianti Hotel REIT, Inc. (PRXA)
PRXA is quoted over the counter, not listed on an exchange. Procaccianti Hotel REIT, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Profile
| Field | Value |
|---|---|
| Ticker | PRXA, quoted over the counter |
| SEC CIK | 0001692345 |
| SEC industry code | Real Estate Investment Trusts |
| Business address | Cranston, RI |
| Incorporated in | MD |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-12 |
| Cash and burn | $11.8M cash; operating cash flow $1.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 6,015,735 (2026-11-12); 6,014,832 a year earlier. | Cover page 2026-11-12 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, Boston, Massachusetts, United States | PCAOB Form AP 2026-04-10 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $12.0M | $3.2M | $3.3M | $11.8M | $66.5M | $32.0M | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $8.9M | $988K | $2.1M | $10.2M | $66.6M | $31.8M | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $5.1M | -$1.8M | $63K | $9.7M | $66.7M | $32.1M | 10-Q 2026-05-11 |
| Q4 2025 2025-12-31 | $6.0M | -$1.4M | -$735K | $10.9M | $67.3M | $32.8M | 10-K 2026-03-23 |
| Q3 2025 2025-09-30 | $11.8M | $2.8M | $3.2M | $13.1M | $66.7M | $33.6M | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $9.2M | $1.4M | $3.5M | $11.1M | $63.9M | $33.0M | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $5.8M | -$934K | $117K | $9.4M | $64.0M | $32.4M | 10-Q 2026-05-11 |
| Q4 2024 2024-12-31 | $6.8M | -$470K | $762K | $11.1M | $64.8M | $31.9M | 10-K 2026-03-23 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2021-08-11 |
| Latest annual report | 10-K | 2026-03-23 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-10-23 |
| Latest proxy | DEF 14A | 2026-09-22 |
Source: SEC EDGAR submissions feed, 234 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier